Molecure S.A.
MOC.WAR
| Exchange: | WAR |
| Currency | Polish złoty |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a chitotriosidase/AMCASE inhibitor that has completed phase I clinical trial for the treatment of sarcoidosis, as well as in preclinical stage to treat idiopathic pulmonary fibrosis and NASH. It also develops OATD-02, an arginase 1 and arginase 2, which is in Phase I clinical trial for the treatment of cancer; USP7, USP21, and YKL-40 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as Onco Arendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland. |
| Address: | Zwirki i Wigury 101, Warsaw, Poland, 02-089 |
| Website: | https://molecure.com |
| Full Time Employees: | 105 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 168360000 |
| Market Capitalization Mln: | 168.36 |
| EBITDA: | -30111584 |
| Wall Street Target Price: | 25.6 |
| Book Value: | 4.75 |
| Earnings Share: | -1.23 |
| Most Recent Quarter: | 2024-03-31 |
| Operating Margin TTM: | -8.30 |
| Return On Assets TTM: | -0.15 |
| Return On Equity TTM: | -0.25 |
| Revenue TTM: | 1521747 |
| Revenue Per Share TTM: | 0.09 |
| Quarterly Revenue Growth YOY: | -0.46 |
| Gross Profit TTM: | -21328 |
| Diluted Eps TTM: | -1.23 |
Valuation
| Price Sales TTM: | 110.63 |
| Price Book MRQ: | 2.06 |
| Enterprise Value: | 142646268 |
| Enterprise Value Revenue: | 999999.99 |
| Enterprise Value Ebitda: | -12.18 |
Shares
| Shares Outstanding: | 16836000 |
| Shares Float: | 10843563 |
| Percent Insiders: | 36.87 |
| Percent Institutions: | 15.71 |
Technicals
| Beta: | 2.10 |
| 52 Week High: | 22.5 |
| 52 Week Low: | 9.6 |
| 50 Day MA: | 12.70 |
| 200 Day MA: | 15.33 |
Earnings
| Report Date: | 2024-10-15 |
| Date: | 2024-09-30 |
| Currency: | PLN |
| Eps Actual: | -0.37 |
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Currency: | PLN |
| Eps Actual: | -0.63 |
| Report Date: | 2024-03-31 |
| Date: | 2024-03-31 |
| Currency: | PLN |
| Eps Actual: | -0.40 |
| Report Date: | 2024-03-29 |
| Date: | 2023-12-31 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.40 |
| Report Date: | 2023-10-31 |
| Date: | 2023-09-30 |
| Currency: | PLN |
| Eps Actual: | -0.25 |
| Report Date: | 2023-09-29 |
| Date: | 2023-06-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.29 |
| Report Date: | 2023-04-27 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.23 |
| Report Date: | 2023-03-30 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.42 |
| Report Date: | 2022-10-31 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.16 |
| Report Date: | 2022-09-29 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.27 |
| Report Date: | 2022-04-29 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.23 |
| Report Date: | 2022-03-25 |
| Date: | 2021-12-31 |
| Currency: | PLN |
| Eps Actual: | -0.48 |
| Report Date: | 2021-10-29 |
| Date: | 2021-09-30 |
| Currency: | PLN |
| Eps Actual: | -0.13 |
| Report Date: | 2021-09-27 |
| Date: | 2021-06-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.20 |
| Report Date: | 2021-03-31 |
| Date: | 2021-03-31 |
| Currency: | PLN |
| Eps Actual: | -0.15 |
| Report Date: | 2021-03-31 |
| Date: | 2020-12-31 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 4.78 |
| Report Date: | 2020-10-31 |
| Date: | 2020-09-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.06 |
| Report Date: | 2020-09-25 |
| Date: | 2020-06-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.03 |
| Report Date: | 2020-04-30 |
| Date: | 2020-03-31 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.06 |
| Report Date: | 2020-03-31 |
| Date: | 2019-12-31 |
| Currency: | PLN |
| Eps Actual: | -0.09 |
| Report Date: | 2019-11-08 |
| Date: | 2019-09-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.06 |
| Report Date: | 2019-09-25 |
| Date: | 2019-06-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.05 |
| Report Date: | 2019-04-26 |
| Date: | 2019-03-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.09 |
| Report Date: | 2018-11-29 |
| Date: | 2018-09-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.05 |
| Report Date: | 2018-09-25 |
| Date: | 2018-06-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -0.10 |
| Date: | 2024-09-30 |
| Eps Actual: | -1.40 |
| Date: | 2023-12-31 |
| Eps Actual: | -1.17 |
| Date: | 2022-12-31 |
| Eps Actual: | -1.08 |
| Date: | 2021-12-31 |
| Eps Actual: | -0.97 |
| Date: | 2020-12-31 |
| Eps Actual: | 4.63 |
| Date: | 2019-12-31 |
| Eps Actual: | -0.45 |